Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods? - Wikidata - wikimedia - TriplyDB

Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

http://www.wikidata.org/entity/Q32034114

about

A 61-year-old man with dyspepsia and weight loss Predictive Efficacy of Interim Positron Emission Tomography/Computed Tomography (PET/CT) for the Treatment of Aggressive Lymphoma Tumor Burden Assessed by the Maximum Standardized Uptake Value and Greatest Diameter on FDG-PET Predicts Prognosis in Untreated Diffuse Large B-cell Lymphoma.Coincidence of follicular lymphoma and hurtle cell thyroid carcinoma in a patient at presentation: which one is the source of bone metastasis? Case report and review of the literature.My treatment approach to patients with diffuse large B-cell lymphoma.Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data.Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era.The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma.18-Fluoro-deoxyglucose positron emission tomography report interpretation as predictor of outcome in diffuse large B-cell lymphoma including analysis of 'indeterminate' reports.Use of subsequent PET/CT in diffuse large B-cell lymphoma patients in complete remission following primary therapy Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients.PET in lymphoma.Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.Maximum standardized uptake value on positron emission tomography/computed tomography predicts clinical outcome in patients with relapsed or refractory diffuse large B-cell lymphoma.Correlating metabolic and anatomic responses of primary lung cancers to radiotherapy by combined F-18 FDG PET-CT imaging.Positron emission tomography scanning in the assessment of patients with lymphoma.[F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model.A Systematic Comparison of 18F-C-SNAT to Established Radiotracer Imaging Agents for the Detection of Tumor Response to Treatment.Qualitative visual trichotomous assessment improves the value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in predicting the prognosis of diffuse large B-cell lymphoma Positron emission tomographic scans in lymphoma: convention and controversy.Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404)Treatment with the MEK inhibitor U0126 induces decreased hyperpolarized pyruvate to lactate conversion in breast, but not prostate, cancer cells.Lymphomatous involvement of gastrointestinal tract: evaluation by positron emission tomography with (18)F-fluorodeoxyglucose Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients Pathological Fractures in Primary Non-Hodgkin's Lymphoma of the Bone: A Case Series with Review of the Literature Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma.Evaluation of cancer treatment in the abdomen: Trends and advances.Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma.The prognostic value of PET and PET/CT in cervical cancer FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma.F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas.Overview of early response assessment in lymphoma with FDG-PET.The utility of body FDG PET in staging primary central nervous system lymphoma Newer Diagnostic Methods in Oncology State-of-the-Art Research on "Lymphomas: Role of Molecular Imaging for Staging, Prognostic Evaluation, and Treatment Response".A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatment Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma.High incidence of false-positive PET scans in patients with aggressive non-Hodgkin's lymphoma treated with rituximab-containing regimens.F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma.

P2860

Q24813742-3F8AD652-0444-4F9F-9B78-8C9C60105595 Q26771059-477DCBD6-05EB-4E6E-9EA5-DEEF7AE42A99 Q33704212-6C05418D-06F5-4BBE-9FB3-D8EC14D89EC1 Q33760931-AAE9A051-FF25-4A86-94C4-C7DC0B507CB4 Q34251964-CB65A025-E0EB-4C76-AB7C-1B4B761EE6BE Q34316959-6C2F9BDC-B216-41F9-9C6D-72BF8AEF68D2 Q34882773-DD6627E1-6429-4906-9825-DA877183FA1B Q35032285-DB3ED3A3-DCBF-47CE-B5FC-A6421586DFD9 Q35064885-98055119-EBFA-4E7D-8F84-69988E967CB7 Q35178725-060379B8-149A-41BA-B32D-E62A71C9A237 Q35626262-1DE64BB6-14FD-471E-B4E4-DCEBA4775BB0 Q35650641-6EE25FA8-3BED-4922-A849-5A1CC7E435CB Q35750990-B01B7C06-9D64-484E-98D8-3F3F2E7C7EFE Q35800656-731004F6-F703-44BB-8EEE-C36CE8DFAE5E Q35843758-C6451C1F-AEAA-4CBE-B612-8812FA9F7CA4 Q35843931-4611AA07-4101-4783-87F8-E63621D090C7 Q35891382-BE4CC992-516B-40F7-9876-86864FFC7245 Q36021562-30E2F999-A49E-41A7-A398-F7B440C089AB Q36121138-0E5A2F5C-FA74-4B26-8C77-E2B5B6F86FFE Q36399538-719B5F8A-3BE2-45AE-89B3-436F455A01D5 Q36417808-A5C3B597-5100-432C-823B-B1930AD330AE Q36488080-48924802-B56A-4545-A699-6330D3D1510C Q36497011-E59EB2DB-59CF-4399-BED2-F433F1C92E9A Q36695611-996E5D43-2724-4B73-A576-391A295CB90E Q36740357-C418E4CA-1CFB-4E46-8B1A-87DE1EB3A050 Q36747993-F71A64EC-235E-42E7-AB94-952B3FD463ED Q36832118-E05B0E89-A6FD-4019-879D-9E4B9648263C Q36836092-F885E223-8C45-4614-BDC7-DC7FF61ED830 Q36836254-D7C0E331-C4B5-43F1-A5AB-AD6E6EEDA2C7 Q36838768-5326108A-13E5-42A9-94E7-83B5DD36B2E4 Q36911500-BA825E47-AFA5-4623-8DDF-266E24F25AD0 Q36927213-3DE3AB1D-6BAF-41FD-A4D2-C674DE3FD11D Q37036944-620ADD5A-7766-4AEB-996F-B88D45357141 Q37040280-814DC554-F938-4265-802C-706FB668C508 Q37144956-80BE3553-CD44-404F-84E8-258186EDD932 Q37200476-BD169C8C-19EC-46FC-A1FF-6A2630AB7E6F Q37240835-9B4CF813-CE15-4B01-BEC1-9DB5CDBC9D36 Q37307649-D44EA9A9-CEDC-490B-B2DA-E9806C6AADF0 Q37321768-7C0E1315-C836-4B34-B98E-13499F528C57 Q37348247-539F6203-1D7D-4B1D-8376-98239713C5BA

P2860

Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

http://www.wikidata.org/entity/Q32034114

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Prognostic value of positron e ...... nventional diagnostic methods?

@ast

Prognostic value of positron e ...... nventional diagnostic methods?

@en

type

label

Prognostic value of positron e ...... nventional diagnostic methods?

@ast

Prognostic value of positron e ...... nventional diagnostic methods?

@en

prefLabel

Prognostic value of positron e ...... nventional diagnostic methods?

@ast

Prognostic value of positron e ...... nventional diagnostic methods?

@en

P1433

Q32034114-0EBC2638-A338-4B77-AC4A-74EFBE3C97A8

P1476

Q32034114-9EB5F52D-C3E9-492A-BB17-97EE2C6B0A68

P2093

Q32034114-1129E0C4-1045-4519-830E-97581DEA4376

Q32034114-3A54DB8B-4B0E-496A-9085-25C586409858

Q32034114-53337172-6961-493C-BB7F-B6DA37B5B0EF

Q32034114-6A8A3692-F135-4AAF-B146-8BEA49101CB4

Q32034114-9A727351-8704-4F3F-B892-EBB1DBD8D614

Q32034114-A1B91B35-B79E-4949-BB4D-3549472CF219

Q32034114-C31831F0-5CBE-4385-B727-FA2249128315

Q32034114-CFD7FECB-0FC3-4E5F-91D7-1A5500D59603

Q32034114-CFED34FD-4BCC-4E09-B4DE-136CB2C2B46D

Q32034114-DAECF252-8704-41C1-A436-42DB177D3488

P304

Q32034114-2CD14C23-651B-4A84-A742-5BFA7B744159

P31

Q32034114-AE5DAEF0-DD51-4481-A2BD-88883EFAF965

P356

Q32034114-47785C1D-193E-422F-B834-D5A54039CB50

P407

Q32034114-AF446CB1-F9C2-40F5-AF8D-DF4BC333D8F2

P433

Q32034114-1024F6A4-44A5-4097-BBDA-F7E955FC6552

P478

Q32034114-03CC7A3C-D556-4A16-A936-9389A381E74B

P50

Q32034114-179F4185-5D59-4F1B-9767-A9DA13655513

P577

Q32034114-4B1F04A5-6DF1-487B-8787-DC8A3AF9D639

P698

Q32034114-6C5C117C-E77E-46B6-A6BF-5BAF237D010C

P921

Q32034114-876e60d1-40e9-4d5c-ae3b-ef2f709e8d7e

Q32034114-E4A86E34-9EBA-4FDB-98E3-22A719DDF89F

P356

JCO.2001.19.2.414

P1433

Journal of Clinical Oncology

P1476

Prognostic value of positron e ...... nventional diagnostic methods?

@en

P2093

C De Wolf-Peeters

http://www.w3.org/2001/XMLSchema#string

G Bormans

http://www.w3.org/2001/XMLSchema#string

G Verhoef

http://www.w3.org/2001/XMLSchema#string

J Balzarini

http://www.w3.org/2001/XMLSchema#string

J Thomas

http://www.w3.org/2001/XMLSchema#string

K Spaepen

http://www.w3.org/2001/XMLSchema#string

L Mortelmans

http://www.w3.org/2001/XMLSchema#string

L Vanuytsel

http://www.w3.org/2001/XMLSchema#string

P Dupont

http://www.w3.org/2001/XMLSchema#string

P Vandenberghe

http://www.w3.org/2001/XMLSchema#string

P304

414-419

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2001.19.2.414

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Sigrid Stroobants

P577

2001-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11208833

http://www.w3.org/2001/XMLSchema#string

P921